Aspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio HldgsAspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio HldgsAspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio Hldgs

Aspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio Hldgs

No trades
Market capitalization
‪7.37 M‬USD
−65.9356USD
‪−12.54 M‬USD
0.00USD
‪3.09 M‬
Beta (1Y)
3.44

About Aspire Biopharma Holdings, Inc.


CEO
Kraig T. Higginson
Headquarters
Estero
Founded
2025
Identifiers
3
ISIN US7389201150
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company was founded on February 2, 2025 and is headquartered in Estero, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.